pixantrone has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biagioli, T; Cavaletti, G; Cavalletti, E; Crippa, L; Dassi, M; Di Luccio, E; Frigo, M; Galbiati, S; Lolli, F; Mazzanti, B; Oggioni, N; Perseghin, P; Riccio, P; Rigolio, R; Rota, S; Sala, F; Sala, V; Stanzani, L; Tagliabue, E; Tredici, G; Zoia, C | 1 |
| Engert, A; Gorbatchevsky, I; Herbrecht, R; Santoro, A; Zinzani, PL | 1 |
1 trial(s) available for pixantrone and Acute Disease
| Article | Year |
|---|---|
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Relapsing Fever | 2006 |
1 other study(ies) available for pixantrone and Acute Disease
| Article | Year |
|---|---|
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis.
Topics: Acute Disease; Animals; Cell Division; Cells, Cultured; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Immunosuppressive Agents; Isoquinolines; Lymphocyte Count; Mitoxantrone; Rats; T-Lymphocytes | 2004 |